N

Nexstim Oyj
OMXH:NXTMH

Watchlist Manager
Nexstim Oyj
OMXH:NXTMH
Watchlist
Price: 8.06 EUR 1% Market Closed
Market Cap: 57.7m EUR

Nexstim Oyj
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Nexstim Oyj
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
N
Nexstim Oyj
OMXH:NXTMH
Revenue
€8.7m
CAGR 3-Years
11%
CAGR 5-Years
21%
CAGR 10-Years
15%
R
Revenio Group Oyj
OMXH:REG1V
Revenue
€103.5m
CAGR 3-Years
10%
CAGR 5-Years
16%
CAGR 10-Years
21%
M
Modulight Oyj
OMXH:MODU
Revenue
€4m
CAGR 3-Years
-26%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
B
Bioretec Oy
OMXH:BRETEC
Revenue
€4.5m
CAGR 3-Years
31%
CAGR 5-Years
21%
CAGR 10-Years
N/A
O
Optomed Oyj
OMXH:OPTOMED
Revenue
€15m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
N/A
B
Biohit Oyj
OMXH:BIOBV
Revenue
€14.3m
CAGR 3-Years
15%
CAGR 5-Years
7%
CAGR 10-Years
15%

Nexstim Oyj
Glance View

Market Cap
57.7m EUR
Industry
Health Care

Nexstim Oyj engages in the provision of medical technology products. The company is headquartered in Helsinki, Etela-Suomen and currently employs 37 full-time employees. The company went IPO on 2014-11-14. The company is focused on improving rehabilitation for stroke patients through the use of noninvasive brain stimulation. Its offering comprises: a diagnostic tool for brain surgery planning, Navigated Brain Stimulation (NBS) System, which comprises navigated transcranial magnetic stimulation (nTMS) device for presurgical mapping (PSM) of the motor and speech cortices; and a device for stroke therapy called Navigated Brain Therapy (NBT) System, which focuses stimulation on targeted locations in the brain in order to enhance rehabilitation process. The NBT System targets upper limb motor disability and is under Phase III pivotal clinical trial study at rehabilitation sites in the United States. The Company’s systems are used in over 100 facilities in research, therapy and neurosurgical planning purposes. Nexstim Oyj has two subsidiaries: Nexstim Inc and Nexstim Germany GmbH.

NXTMH Intrinsic Value
10.71 EUR
Undervaluation 25%
Intrinsic Value
Price
N

See Also

What is Nexstim Oyj's Revenue?
Revenue
8.7m EUR

Based on the financial report for Dec 31, 2024, Nexstim Oyj's Revenue amounts to 8.7m EUR.

What is Nexstim Oyj's Revenue growth rate?
Revenue CAGR 10Y
15%

Over the last year, the Revenue growth was 21%. The average annual Revenue growth rates for Nexstim Oyj have been 11% over the past three years , 21% over the past five years , and 15% over the past ten years .

Back to Top